Methotrexate for Psoriasis in Weekly Oral Doses

Morphologic and Physiologic Effects of Chemotherapeutic Agents in Psoriasis11From the Dermatology Service, General Medicine Branch, National Cancer Institute, (National Institutes of Health, Public Health Service, U.S. Department of Health, Education, and Welfare) Bethesda, Maryland.

1959 • 154 citations

Methotrexate for Psoriasis

1967 • 154 citations

Treatment of Psoriasis with Folic Acid Antagonists

1958 • 143 citations

Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists.

1955 • 98 citations

Folic Acid Antagonists

1963 • 90 citations

Aminopterin for Psoriasis

1955 • 89 citations

Folic Acid Antagonists

1952 • 78 citations

CHROMOSOMAL ABNORMALITIES PRODUCED BY FOLIC ACID ANTAGONISTS.

1965 • 76 citations

Methotrexate vs. Aminopterin for Psoriasis

1961 • 39 citations

Parenteral vs. Oral Folic Acid Antagonists

1964 • 34 citations

Further Observations on Aminopterin for Psoriasis11From the Division of Dermatology, Department of Medicine, University of California School of Medicine, San Francisco, California.

1959 • 32 citations

Studies on the folic acid vitamins.III. The duration of the effects of the folic acid antagonists in man

1960 • 24 citations

Management of Psoriasis Using Methotrexate Orally in a Single Weekly Dose

1966 • 22 citations

METHOTREXATE IN THE TREATEMNT OF PSORIASIS: A CONTROLLED CLINICAL TRIAL

1963 • 20 citations

Folic-acid Antagonists in Treatment of Psoriasis

1965 • 20 citations

Methotrexate for Psoriasis: A Preliminary Report

1965 • 17 citations

A Study of the Folic Acid Antagonists in the Treatment of Psoriasis (Aminopterin vs. Methotrexate vs. Aminopterin and a Corticosteroid)

1963 • 14 citations

The Use of Folic Acid Antagonists and Steroids in Treatment of Psoriasis

1963 • 10 citations

Keratoacanthomata in generalized pustular psoriasis.

1963 • 6 citations

METHOTREXATE IN PSORIASIS

1968 • 5 citations

Cited By (0)

Loading...